GeneLink appoints James Monton to board
This article was originally published in Clinica
Executive Summary
Consumer genomics specialist GeneLink has appointed James Monton to its board of directors, where he will serve on the audit and compensation committees. Mr Monton has "decades of product development and branding experience" in health and beauty care for Proctor & Gamble, and currently serves on the boards of Northern Kentucky University's Business School and the International Business Center. Longwood, Florida-based GeneLink's products include lipid metabolism, bone health and cardiovascular assessments, which analyse single nucleotide polymorphisms (SNPs) associated with these fields. It is also developing panels assessing dementia and Alzheimer's disease, and metabolic syndrome.